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Actual diagnostic approach to the acute
stroke patient
Abstract Since acute stroke is now
considered a potentially treatable
medical emergency, a rapid and cor-
rect diagnosis must be made. The first
step is to exclude hemorrhage, then to
visualize any early ischemic changes,
demonstrate the presence of hypoper-
fusion and locate the presence of a
vascular underlying pathology as well
as elucidate the presence of a potential
penumbra (tissue at risk). Thanks to
improvements and advances in both
MR and CT technology, this can now
be done in a number of ways. At the
moment, CT is the most widely
available and fast method for obtain-
ing imaging of the brain and neck
vessels of patients presenting with
acute stroke. MRI can provide more
precise information, although it re-
mains slightly more time-consuming,
but is, however, the method of choice
for follow-up imaging. The main point
is to take the one-stop-shopping ap-
proach where imaging of the vessels
and brain is done from the aortic arch
to the circle of Willis in one single
session in order to have all the
necessary information in the acute
phase.
Keywords Stroke . Computed
tomography . Magnetic resonance
imaging . Penumbra . Diffusion
imaging
Introduction
Imaging and acute stroke
Until 10 years ago, stroke was considered a hopeless dis-
ease for the patients it affected, who would spend their life
with major handicaps or in extensive rehabilitation pro-
grams. Therefore, there was no need for imaging to
provide any detailed information about the parenchyma
and vessels in the acute stage, but was mainly used to
demonstrate hemorrhage or for follow-up of intracerebral
lesions. This was the case until the first positive study on
the use of rTPA in stroke was performed and showed
improvement when patients were treated acutely intrave-
nously [1]. This pioneering study was partly reproduced by
the ECASS studies [2, 3], but less spectacularly, and
mainly by demonstrating that stroke could be approached
as a treatable disease. It opened the way for groups to study
further possibilities such as intra-arterial thrombolysis
using other thrombolytics such as urokinase [4–6] or
recently even mechanical thrombus extraction [7, 8].
Indeed, evidence points to the advantage of also treating
the clot itself more directly. All these advances have thus
prompted the need for improved imaging at all the levels
of the brain and neurovascular tree.
Thus, in order to optimize treatment, even in the acute
phase, it is of prime importance to perform a complete
neurovascular imaging session in one go, adopting the one-
stop shopping approach where imaging of the vessels and
brain is done from the aortic arch to the circle of Willis; this
will provide the radiologist and the clinician with the
complete picture needed in order to start treatment (Figs. 1
and 2). Indeed, it is not simply important to see whether
something has happened at the level of the brain, but also to
localize the level of the vascular pathology that is causing
it, be it at the level of the circle of Willis, the cervical
carotids or even the aortic arch (and even as low as in the
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and CT angiography techniques, this is now unproblematic
with both modalities. It is thus possible to determine the
type of stroke [9] and its possible cause [10]. Indeed, while
atherosclerosis is the most common type of cause, other
causes may occur that have different treatments such as
arterial dissection, small vessel disease, inflammatory and
non-inflammatory vasculopathy and vasomotor disorders
[10]. Also, the stroke itself may be classified into various
groups either due to anatomic localization or etiologies [9].
Exclusion of hemorrhage
Indeed, since we are considering using thrombolysis, it is
imperative to at first exclude intracerebral hemorrhage.
This was done for a long time because CT in general was
easier to perform in the setting of stroke. Due to the
development of standardized MR imaging protocols with
diffusion imaging [11–13], MRA and susceptibility imag-
ing, it has become possible to image the possibly ischemic
brain within an acceptable timeframe (i.e., less than
20 min). In clinical practice the exclusion and demonstra-
tion of hemorrhage can still be best done by CT, even
though MRI has been shown by many authors to be able to
detect acute bleeding by using a combination of sequences
[14–16], mainly gradient echo sequences and even diffu-
sion-weighted imaging using echo-planar technology.
Indeed, MRI should in theory be more sensitive to hem-
orrhagic changes [17–19], but the findings are often
somewhat confusing to the non-initiated clinician. While
MRI can be used to demonstrate hemispheric hemorrhage
(Fig. 3), its utility in demonstrating more subtle blood as
found in subarachnoid hemorrhage still has to be demon-
strated clinically (Fig. 4). CT, however, has been used in
the main published trials since it remains easier to use and
to interpret when facing the possibility of the occurrence
of acute hemorrhage. Recent studies such as that of
Nighogossian have shown that the use of T2* images can
detect microbleeds indicative of potential hemorrhage [20].
Demonstration of ischemic lesions
Computed tomography
Computed tomography signs of acute early cerebral ische-
mia are well known and established [21, 22]. These arise
mainly from the presence of early edema. This edema will
lead to hypodensity (Fig. 5) and to a diminished distinction
of white and grey matter structures: loss of clear visual-
ization of the insular ribbon (Fig. 6) and lenticular nucleus
(Fig. 7) as well as the loss of cortical differentiation
(Fig. 8). The sign that is the most important to recognize is
the presence or absence of early edema, since this very
Fig. 1 MRI all-in-one approach
in a patient with right-sided
carotid dissection. The diffu-
sion-weighted image shows a
hyperintense lesion in the basal
ganglia (a). The Gd-MRA (b) of
the whole carotid system dem-
onstrates an occlusion of the
right carotid after the bifurcation
and the rotated image shows a
typical tapering of the carotid
lumen (c), indicative of a dis-
section. In the petrous portion of
the carotid, there is hyperinten-
sity instead of the flow void
(arrow)
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often has therapeutic impact. These signs have been dem-
onstrated to be well recognizable by trained physicians [23,
24]. Beginning hypodensity corresponding to decreased
X-ray absorption by the tissue corresponds to water ac-
cumulation. When this early hypodensity is visible in more
than 30% of the affected MCA territory, there is an in-
creased risk of secondary bleeding if thrombolysis is
started; this was an important finding of the ECAS study
[25, 26] (Fig. 9).
Also of diagnostic importance is the presence of dense
arteries, signifying acute occlusion: this sign will be found
at any location, but is most easily recognized at the level of
the MCA or the basilar artery [27, 28]. At the level of the
MCA, this sign has been recognized in approximately 40%
of cases. Gadda et al. have found it to be a predictor of a
more restricted extension of the infarct using multidetector
CT images [29]. Some false-positive situations such as
hyperviscosity, high erythrocyte counts, vascular calcifica-
tion and childhood are important to know (Figs. 10 and 11).
Magnetic resonance imaging
While conventional magnetic resonance imaging, espe-
cially T2-weighted imaging, is not very sensitive to the
changes associated with ischemia before 8 to 12 h [30–33],
it was the development of newer and more robust diffusion
and perfusion sequences that allowed MRI to enter the
clinical arena of stroke neurology. This was due to the
development of clinically available echo-planar scanners,
capable of scanning the whole brain in less than a second
[34]. Thus, diffusion and perfusion MR techniques were
made available that could quickly image patients with a
clinical suspicion of stroke. Diffusion imaging was devel-
oped by Le Bihan and consists of a spin-echo sequence that
is modified to be sensitive to tissue motion [35]. In acute
stroke, the sequence of events of the ischemic cascade
leads to an early local water shift from the extra- to intra-
cellular compartments (without a global water increase
initially: hence the normal T2-weighted images), which
Fig. 2 Multimodality CT in a
patient with acute left hemi-
spheric stroke. There is begin-
ning hypodensity with mass
effect in the left MCA territory
(a). The angio-CT is recon-
structed in the sagittal and cor-
onal planes (b–d). The coronal
reconstruction shows an occlu-
sion of the M1 segment on the
left (arrow) (c)
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causes a decrease in the diffusion (and apparent diffusion
coefficient), which is reflected in an increased signal on the
diffusion-weighted image with the maximal b value (usually
1,000) [36] (Fig. 12). The first clinical applications were
performed by Warach and Chien and used as the first
clinical scanners with slower sequences that were more
prone to motion-induced artifacts [37, 38], but later on
echo-planar imaging allowed whole-brain imaging studies
to be performed routinely [39, 40]. Diffusion imaging thus
provides images of acute stroke with a high sensibility and
specificity, as was shown by Lövblad et al. [41] and Gonzales
et al. [42]. Reports on humans have shown them to occur
within 1 h. Indeed, one of the earliest reports showsDWI to be
positive 39 min after the onset of symptoms [43]. We have
also observed this to occur in random cases where the
ischemic event occurred in the hospital in the presence of a
physicianwhowas able to report the exact start of events. This
has allowed people to compare the diffusion hyperintensity to
the early ECG signs in cardiac stroke [44]. In the largest study
of patients studied with DWI in stroke, Lövblad et al. found
that diffusion-weighted MR imaging studies were positive in
133 of 151 cases of infarction (88% sensitivity) and negative
in 41 of 43 cases with no infarction (95% specificity) [41].
Two cases identified as positive on diffusion-weighted images
had non-ischemic diagnoses (1.5% false-positive rate). Dif-
fusion-weighted imaging had a positive predictive value of
98.5% and a negative predictive value of 69.5%. Use of T2-
weighted sequences as well as diffusion-weighted imaging
produced no false-positive findings. Of the negative scans,
69.5% corresponded to transient ischemic attacks or infarcts
(mostly small brain stem infarcts). When only cases scanned
within 6 h of onset were considered, the sensitivity rose to
94% and the specificity to 100%. When imaging patients
within 6 h, Gonzalez et al. found 100% sensitivity and 86%
specificity for diffusion-weighted MR imaging [42]. Further
expanding this series, they found that, in the diagnosis of
stroke in the early period (<12 h after presentation), DWI is
superior to conventional MR imaging and CT [45] (Fig. 13)
and due to its higher capacity to detect lesionsmay also help in
differentiating hemodynamic strokes from embolic strokes.
Indeed, very often hemodynamic lesions will have a typical
“string of pearls” appearance with multiple lesions located in
the typical watershed areas (Fig. 14).
Diffusion techniques have also been shown to be supe-
rior to plain CT in a series of papers [46, 47], but these
findings still need to be validated. MR imaging is clearly
indicated to perform the follow-up of patients, especially
when recanalization has been performed, since ADC
Fig. 3 Patient with acute lobar
hemorrhage: the DWI image
shows a mass lesion in the left
frontal lobe (a) that is inhomo-
geneous with both hypo- and
hyperdense areas. The T2-
weighted image shows a defined
lesion that is slightly hyperin-
tense (b), whereas on T1-
weighted images it is isointense
(c) and does not enhance (d)
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values can show the depth and extent of the ischemia [48].
This has been useful since DWI lesions have been shown to
diminish and the ADC values to revert partially or
completely to normal following therapy, in agreement
with previous animal data [48–53]. Some authors have
even further demonstrated that the ADC can predict clinical
outcome, i.e., the lower the ADC, the worse the clinical out-
come, as shown by Oppenheim et al. in their studies [54, 55].
Venous ischemia
While more frequent and less mortal than has been initially
thought, venous cerebral occlusive disease is sometimes
very difficult to diagnose in the early stage. Computed
tomography is superior to magnetic resonance imaging
since CT venography corresponds more exactly to digital
subtraction venography [56]. Magnetic resonance tech-
niques such as contrast-enhanced MR phlebography may
more reliably demonstrate cortical venous thromboses and
is also suggested for follow-up due to the lack of radiation
[57]. Also diffusion and perfusion techniques provided by
MRI can deliver more information about the integrity of the
surrounding cerebral tissue [58] (Fig. 15).
False-negative imaging and stroke-mimicking
syndromes
Whenever confronted with a patient who has acute neg-
ative imaging, it is important to perform a second imaging
study, very often MRI, to determine whether we are dealing
with a patient with a pathology mimicking stroke or not.
False DWI negatives and positives
Magnetic resonance and diffusion-weighted MRI may be
normal in stroke-like syndromes [59] and may even under
certain circumstances be normal in strokes [60]. In transient
ischemic attacks, diffusion MRI demonstrates ischemic
abnormalities in nearly half of the clinically defined TIA
patients [61] (Fig. 16); this has a relatively important im-
plication since it means that these patients did not suffer
from hemodynamic symptoms, but from a stroke with
Fig. 4 Acute subarachnoid hemorrhage: CT (a, b) shows hyperdensity
in the right sylvian fissure (arrow). On the FLAIR images, there are
hyperintensities in the sulci on the surface of the right frontal lobe (c).
On DWI there is also a sylvian hyperintensity (arrow) (d). On T2- and
T2*-weighted images there are also areas of perturbed signal (arrows)
(g, h)
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transient symptoms. This will mean that the patient might
benefit from the same treatment as a patient with a large
hemispheric stroke (i.e., thrombolysis).
Stroke mimics
The aim of imaging is not just to include into therapy any
patient who has no hemorrhage and a DWI hyperintensity,
Fig. 6 Patient with clinical
symptoms of stroke for 2 h.
Effacement of the insular ribbon
in the left hemisphere (arrow)
(a). There is also discrete sulcal
effacement. On the DWI image
there is a slight hyperintensity in
the left insular region (b)
Fig. 5 Acute CT showing slight hypodensity in the left MCA
territory (a). The raw angio-CT source images show occlusion of the
left MCA (b). The perfusion CT shows significantly decreased
perfusion in the left MCA territory (c), corresponding to the
occlusion of the distal M1 segment seen on the reconstructed angio-
CT (d). Follow-up MRI shows hyperintensity on the DWI image (e)
and hypodensity on the ADC (f), corresponding to acute infarction.
Follow-up CT demonstrates progression of edema and beginning of
herniation of the midline (g)
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but also to detect some stroke-like situations that might
look like a cerebrovascular event. This is an area of clinical
neuroimaging where MRI is clearly superior to CT. A few
pathologies exist that closely resemble a stroke on DWI,
namely infectious diseases and epilepsy.
Concerning epilepsy, diffusion imaging is sensitive to
the changes observed in epilepsy. In the chronic phase,
there are very discrete changes that can be observed in the
ADC, whereas in the case of patients with status
epilepticus, hyperintensities have been observed in the
affected cortex. This corresponds well to what has been
observed in experimental models of epilepsy and to what
has been observed in cases of well-documented experi-
mental spreading depression. Indeed, in spreading depres-
sion, waves of ADC reductions have been seen in the
cortex corresponding to waves of depolarizations. Thus,
DWI is very sensitive to neurophysiologic changes oc-
curring in the cortex. However, in the acute phase these
DWI hyperintensities are accompanied by hyperperfusion
and not hypoperfusion as in stroke [62]. This supports the
validity of ADC measurements in acute stroke, which
despite some controversy seem related to tissue outcome.
Demonstration of underlying hypoperfusion
This is done by perfusion imaging, performed either with
MRI or CT technology.
MR imaging
The advent of fast imaging techniques such as echo-planar
imaging and/or gradient-echo imaging has allowed us to
Fig. 7 Patient with acute stroke of 1.5 h onset: the acute CT shows disappearance of the left-sided lenticular nuceus (arrow) (a). On the
follow-up MRI (b) and CT (c) there is an ischemic lesion with hemorrhagic inclusions (hypointense on MRI, hyperdense on CT)
Fig. 8 Patient with acute right-
hemispheric stroke of 2.5 h
onset. Sulcal effacement over
the right hemisphere on acute
CT (a). On follow-up MR 2
days later there is a large area of
the right MCA territory that is
infarcted (b)
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acquire MR images quickly and repeatedly that are sen-
sitive to changes induced by contrast materials [63].
Perfusion of the brain with MRI is done principally with
three techniques: contrast-enhanced techniques [64–66],
arterial spin-labeling techniques [67] and the BOLD
principle. The BOLD technique is mainly used in func-
Fig. 9 Beginning hypodensity and mass effect in the left MCA territory (a–c). The hypodensity corresponds to more than 33% of the
territory. After thrombolysis, the next day there is massive hemispheric bleeding and brain herniation (d–f)
Fig. 10 Patient with left hemi-
spheric stroke: on the unen-
hanced CT iamges there is a
hyperdensity of the MCA (a)
and the terminal portion of the
internal carotid artery (b), which
corresponds to occlusion. This
occlusion is seen on the angio-
CT with corresponding deep
hypoperfusion of the left
hemisphere
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tional activation imaging and has been used in stroke [68,
69]. The problem with contrast-derived MR perfusion
techniques is that one measures variations in the magnetic
field that represent extreme susceptibility artifacts, render-
ing quantification difficult (e.g., the measurement of CBV
and CBF). Also, we are mainly using relative values, since
no reliable arterial input function is obtained. Studying
various parameters from T2* imaging, Sorensen found that
lesion volumes on blood volume and diffusion maps cor-
related better with eventual infarct volumes than did those
on blood flow and tracer mean transit time maps [70]. T1-
weighted MR perfusion imaging is possible and probably
advantageous, but it has not yet established itself as a viable
option [71].
However, the use of PWI in addition to DWI has allowed
Steven Warach [72], among others, to develop a model of
penumbra that can be used in clinical practice. The central
area of diffusion anomaly at the first time point corre-
Fig. 11 Patient with progressive coma: on unenhanced CT there is a
hyperdense basilar artery (a). The occlusion of the basilar artery is
confirmed on angiography with a stop at the end of the basilar artery
(b), while angiographic reperfusion is good after local intra-arterial
thrombolysis (c) with visualization of the posterior cerebral arteries
(d); the next day there is progressive ischemia in the posterior fossa
(e) with hemorrhagic transformation already visible on CT, but
better seen on MRI (f–h)
Fig. 12 Operational definition of the penumbra: in this patient with an acute right-hemispheric stroke there is a large DWI hyperintensity
(a) surrounded by a larger area of hypoperfusion (b). This area is the potential penumbra. Angio-MR revealed a carotid occlusion (c)
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sponds to the ischemic core, while the hypoperfused area
surrounding it represents the penumbra, or tissue at risk of
undergoing further infarction if nothing is undertaken. This
model has been proven usable clinically by many authors
since then.
CT
Recently, much emphasis has been placed on the use of CT
perfusion techniques for the acquisition of cerebral perfu-
sion maps, even at low injection rates [73]. Wintermark et
al., after having validated perfusion CT in stroke with
Fig. 13 CT vs. MRI in acute stroke: CT done on admission shows slight sulcal effacement in the right frontal lobe (a). MRI was performed
right afterwards, and on DWI there is a clearly visible hyperintensity (b), seen as a hypointensity on the ADC map (c)
Fig. 14 Patient with hemody-
namic stroke due to stenosis: on
CT there is a hypodensity in the
right-sided occipital lobe (a). On
the DW images one can see
multiple lesions (b–d) arranged
in a string-of-pearls fashion in
the watershed areas over the
surface of the brain
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Xenon CT [74], showed that it is possible to acquire
dynamic perfusion CT (PCT) with deconvolution, which
produces maps of time to peak (TTP), mean transit time
(MTT), regional cerebral blood flow (rCBF), and regional
cerebral blood volume (rCBV), with a computerized au-
tomated map of the infarct and penumbra. They found that
dynamic perfusion CT maps are more accurate than non-
enhanced CT in detecting hemispheric strokes. However,
perfusion CT still has a limited spatial coverage, which
should be overcome with more detector arrays [75], since
new generations of CT units have up to 64 arrays.
Demonstration of underlying vascular pathology
While conventional, or nowadays digital subtraction an-
giography remains the gold standard for the demonstration
of any vascular pathology, including occlusion, it cannot be
performed routinely in all cases with suspected strokes,
partly because of the radiation exposure, duration of the
examination and also because it is not available every-
where where the diagnosis and treatment are initiated.
Besides the dense artery signs described above that are
indirect signs of vascular occlusion on plain CT, the direct
demonstration of vascular pathology necessitates either
angio-CT or MR angiography; indeed, both of these
techniques now permit the visualization of the vascular tree
from the aortic arch to the circle of Willis. Angio-MRI is
usually performed in two stages: first a 3-D time-of-flight
sequence is performed for the intracranial vasculature
because of its high spatial resolution and then a contrast-
enhanced MR sequence is performed [76]. This sequence is
a dynamic fast sequence that provides a robust lumino-
graphy of the examined vessels. Remonda et al. in a series
of 120 patients have demonstrated that the grading of
Fig. 15 Patient with thrombosis of the superior sagittal sinus (SSS):
on unenhanced CT the SSS is prominent and spontaneously
hyperdens (a). After contrast administration there is a so-called
empty triangle or delta sign (b). On DWI the thrombus is
hyperintense (c), and is also hyperintense on T2-weighted images
(d). The MR venography demonstrates irregularity of the posterior
portion of the SSS (e), seen on the sagittal T1-weighted image (f), as
well as on the CT venogram (g)
Fig. 16 Patient with transient right-sided symptoms, mimicking a
transient ischemic attack. In this case the initial DWI shows a lesion
in the left striatum (a), whose edema compresses the posterior limb
of the internal capsule
1263
stenoses on Gd-enhanced MR angiograms agreed with the
grading of stenoses on DSA images in 89% of arteries [77].
CT angiography (CTA) has improved technically so that it
is easily feasible using deconvolution techniques that allow
both CTA and perfusion studies within one simple imaging
protocol. Indeed, Sims et al. in a study of 47 patients with
acute MCA occlusion found that patients with patent vas-
culature or occult distal occlusion on CTA before treatment
have a better clinical outcome as well as better chances of
early improvement and early independence with fewer
Fig. 17 Patient with left-sided carotid dissection. On non-enhanced
CT there is a slight hyperdensity of the left carotid artery in the distal
cervical segment (arrow) (a). After contrast injection there is no
enhancement of the occluded carotid (b). DWI shows ischemia in
the left basal ganglia (c). On T2-weighted images there are no flow
voids in the carotid lumen (d), and there is hyperintensity as well on
the T1-weighted images with fat suppression (e). MRA shows the
occlusion of the left carotid (f). Angiography shows the typical
tapering of the carotid lumen (g), and parenchymography reveals a
perfusion deficit over the left hemisphere (h)
Fig. 18 Massive calcification at the level of the aorta (a) and carotids (b–d) seen on this CT examination that covers the upper thoracic and
neck regions (c, d)
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Fig. 19 Bilateral calcification and stenoses (arrows) of the carotid arteries, seen in the coronal (a), axial (b) and sagittal (c) planes on angio-CT
Fig. 20 Patient with basilar artery occlusion. Unenhanced CT
shows hyperdensity of the basilar artery (a), and the angio-CT
demonstrates the thrombus directly. The DWI image shows
hyperintensities in the pons (c), seen bilaterally, more marked on
the right, also on the FLAIR images. On the axial FA maps, there are
low FA values in the pons (d), and the reconstructed tensor images
show degeneration of the right-sided internal capsule (f)
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hemorrhages [78]. The method employed should be able to
direct the clinician and be able to demonstrate the
possibility of proximal as well as distal vascular disease
(Figs. 17, 18, 19).
Demonstration of the penumbra
Even though the exact definition of the penumbra has
varied over the years since its original description [79], the
ischemic penumbra corresponds to an ischemic brain
region in a state of diminished cerebral blood flow that has
not yet led to complete infarction and is potentially
salvageable. It was believed to be situated between the
thresholds for functional impairment and morphologic
damage, and it is considered to be a dynamic process [80].
The penumbra in humans has been traditionally studied by
nuclear medicine brain perfusion techniques such as
positon emission tomography (PET) and single photon
emission computed tomography (SPECT), but recently
magnetic resonance imaging (MRI) techniques have also
allowed us to gain insight into the mechanisms underlying
ischemia. Traditionally, based on those cerebral blood flow
studies, the ischemic penumbra has been defined as tissue
with flow within the thresholds for maintenance of function
and of morphologic integrity. The penumbra has recovery
potential and therefore is the target for interventional
therapy in acute ischemic stroke. It seems important to
know that apparently early flow disturbances leading to
rapid cellular damage are the major contributor to infarc-
tion, meaning that therapy should be targeted to the initially
hypoperfused regions. More importantly, it has been
demonstrated that functional imaging could represent a
correlator for functional recovery after stroke or after
thrombolysis. At first very motion-sensitive, functional
MR techniques have entered a new age with the clinical
introduction of echo-planar imaging, allowing such meth-
ods as diffusion- and perfusion-weighted MRI (DWI and
PWI) to be performed more rapidly, therefore minimizing
patient motion artifacts. In a proposed model, the so-called
diffusion-perfusion mismatch represents the penumbra
where the central diffusion defect at the initial time point
corresponds to the penumbra and the surrounding hypo-
perfused area corresponds to a potential penumbra [81].
This model been proven useful in the clinical routine by
further groups [82]. Other MR methods such as MR
spectroscopy have also shown promise in the evaluation of
the penumbra. Also, more advanced MR techniques based
on the diffusion acquisition scheme such as diffusion
tensor techniques are believed to show promise, especially
since early changes in the tensor seem to accompany acute
ischemia [83–90], and the tensor images eventually can
demonstrate secondary Wallerian degeneration (Fig. 20).
Recently, due to the development of fast CT detectors, it
has been possible to obtain stable perfusion maps of the
brain. Using their model for the calculation of cerebral
perfusion maps, Wintermark et al. found that, regarding the
capacity to detect the penumbra in stroke patients, perfu-
sion CT and MR diffusion and perfusion methods are
equivalent [91].
Conclusion
Thanks to advances in MR and CT technology, it is now
possible to image the brain and the whole neurovascular
axis in a few minutes. This will help to contribute in a
significant way to the treatment of acute cerebral ischemia.
Indeed, while it is important to see what is or is not
happening at the level of the cerebral parenchyma, the
clinician involved in the diagnosis and management of
stroke must also apprehend at an early stage what exactly
the underlying cause of the ischemic lesion is. He or she
therefore has to perform high-resolution imaging at the
level of the cranio-cervical arteries. This will lead to the
adoption of the so-called one-stop-shopping approach,
where in one session, he or she will obtain not just the
information on whether thrombolysis can be performed
safely, but will also gain insight into possible proximal
vascular or cardiac causes of the stroke. While it seems that
MR technology together with diffusion imaging provides a
more sensitive method that also provides more exact and
objective data, CT has recently gained in acceptance [92].
When using MR methods, it will be necessary in the
future also to use and evaluate all the parameters provided,
not simply diffusion and perfusion imaging, but also to
look in detail at the ADC maps in order to determine what
is reversible and what is not, as well as to integrate findings
from diffusion tensor images that could on the one hand go
further into the penumbra and on the other hand provide
insight into the re-organization of the ischemic brain by
using the tractographic data also provided.
While on the one hand hemorrhage must be excluded, on
the other, pathologies that can mimic stroke must be taken
into account, such as venous thromboses. This can be done
by performing an all-inclusive imaging protocol with both
CT and MR technology.
However important these improvements in imaging
quality might seem, it is extremely important not to forget
to integrate further variables such as clinical scales and
time to imaging into the whole picture. This led Baird and
Warach to develop their three- and four-item scales that
needed to be integrated into the evaluation of images in
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